BackCEN Biotech Overview

CEN Biotech Receivables

CEN Biotech's receivables is $110K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$114741.00
↑ 151.28% YoYΔ $69078.00 vs prior year quarter

Peer trimmed avg / median

Loading

CEN Biotech Receivables History

Loading

CEN Biotech vs. peers: Receivables Comparison

Loading

CEN Biotech Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CEN Biotech (CENBF) FAQ

CEN Biotech (CENBF) currently reports a receivables of $110K as of September 2023. That compares with $46K in the prior-year period — up 151.3% year over year. Use the charts on this page to explore CEN Biotech's receivables history and peer comparisons.

CEN Biotech's receivables increased from $46K to $110K — a 151.3% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CEN Biotech reported $110K in receivables as of September 2023. That compares with $46K in the prior-year period — up 151.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $110K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CEN Biotech, and consider following CENBF for alerts when major investors trade the stock.